Cellebrite DI: Strong Q3, But Valuation And Technical Issues Could Weigh On The Stock (Rating Downgrade)
2025-11-21 23:39:17 ET
This article is ongoing coverage of Cellebrite DI ( CLBT ), which I last wrote about in November 2024 . In my last article, I discussed how Cellebrite had strong long-term growth potential. I also explained that the valuation increase and the technical set-up could lead to a profit-taking pullback. It looks like the higher valuation and the technical level led to a sell-off from February to July 2025. The stock has dropped 9% since my last article....
Read the full article on Seeking Alpha
For further details see:
Cellebrite DI: Strong Q3, But Valuation And Technical Issues Could Weigh On The Stock (Rating Downgrade)NASDAQ: CLBT
CLBT Trading
-1.27% G/L:
$14.40 Last:
289,614 Volume:
$14.53 Open:



